FibroBiologics/FBLG

$11.35

-3.81%
-
1D1W1MYTD1YMAX

About FibroBiologics

FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.

Ticker

FBLG

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Pete Oheeron

Employees

10

Headquarters

Houston, United States

FibroBiologics Metrics

BasicAdvanced
$386M
Market cap
-
P/E ratio
-$0.91
EPS
-
Beta
-
Dividend rate
$386M
$55.00
$6.53
69K
1.003
11.253
-60.47%
307.331
308.129
-480.16%

FibroBiologics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$0
NaN%
Net income
-$9.7M
361.9%
Profit margin
0%
NaN%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for FibroBiologics stock?

FibroBiologics (FBLG) has a market cap of $386M as of May 19, 2024.

What is the P/E ratio for FibroBiologics stock?

The price to earnings (P/E) ratio for FibroBiologics (FBLG) stock is 0 as of May 19, 2024.

Does FibroBiologics stock pay dividends?

No, FibroBiologics (FBLG) stock does not pay dividends to its shareholders as of May 19, 2024.

When is the next FibroBiologics dividend payment date?

FibroBiologics (FBLG) stock does not pay dividends to its shareholders.

What is the beta indicator for FibroBiologics?

FibroBiologics (FBLG) does not currently have a Beta indicator.

What is the FibroBiologics stock price target?

The target price for FibroBiologics (FBLG) stock is $, which is 100% below the current price of $11.35. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell FibroBiologics stock

Buy or sell FibroBiologics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing